CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Abroad (travel likely)RecruitingPHASE2

Conditions

CMV · Allogeneic Stem Cell Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California, United States
Contact: Study coordinator (Piyanuch Kongtim, MD, PhD) · ucstudy@uci.edu · 877-827-8839

Study leads

Piyanuch Kongtim, MD,PhD
Principal Investigator
Chao Family Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

CMV Viremia

Abroad (travel likely)RecruitingPHASE2

Ljubljana, Slovenia

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

BKV Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Pathogen Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

Study Evaluating the Efficacy and Safety of Artesunate

CMV Infection

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Rochester, United States